Logo
    Search

    Schizophrenia with Dr. Cummings: Controversies, Brain Science, Crime, History, Exercise, Successful Treatment

    aaMarch 06, 2018

    Podcast Summary

    • Understanding Schizophrenia: Reality vs False SignalsSchizophrenia is a genetic and neurological disorder causing loss of reality distinction, leading to psychosis and cognitive deficits. Long-term medication use remains controversial, individualized treatment is crucial.

      Schizophrenia is a spectrum of illnesses characterized by a loss of ability to distinguish reality from false signals in the brain. This impairment leads to psychotic symptoms such as delusions and hallucinations. The disorder also presents negative symptoms like emotional blunting and cognitive deficits. The condition is not a choice, but rather a genetic and neurological issue. It's important to remember that many people have occasional false perceptions, but those with schizophrenia cannot dismiss them as unreal. The discussion also touched upon the controversy surrounding long-term medication use and the importance of optimizing treatment for individuals with schizophrenia.

    • Understanding Hallucinations in SchizophreniaPeople with schizophrenia struggle to distinguish reality from non-reality, leading to distressing hallucinations and delusional thoughts. These experiences can vary in sensory modalities and can be influenced by cultural contexts.

      Individuals with schizophrenia have a compromised ability to distinguish reality from non-reality, leading to hallucinations and delusional thoughts. These experiences can be distressing and vary in sensory modalities, with auditory hallucinations being the most common. The human brain usually filters out unusual experiences, but for those with schizophrenia, these experiences are perceived as real. For instance, someone might hear their name in an empty room and believe it's a divine message or a warning from demons. These beliefs can evolve based on cultural contexts and historical events. Hallucinations can manifest as frightening images, sounds, smells, tastes, or tactile sensations. A patient might, for example, believe worms are crawling on their legs due to a hallucination or an actual medical condition like cellulitis. It's crucial to understand that hallucinations are false sensory signals, while illusions are distorted perceptions of real stimuli.

    • Hallucinations and delusions in psychotic illnesses can result from the brain filling in gaps with threatening or otherworldly information.Hallucinations and delusions in psychotic illnesses can distort normal brain functions, leading to threatening or otherworldly interpretations of partial information. Antipsychotic medications can worsen negative symptoms and impair cognition, but they have extended the course of the illness.

      Our brain's natural ability to be vigilant and fill in gaps in our environment can lead to hallucinations and delusions in individuals with psychotic illnesses. Hallucinations, such as auditory hallucinations of multiple voices, can be a result of the brain interpreting partial information as something threatening or otherworldly. These symptoms, along with negative symptoms like lack of motivation and flat affect, are distortions of normal physiologic functions in schizophrenia. Antipsychotic medications, particularly dopamine antagonists, can worsen these negative symptoms and impair cognition. Historically, the progression of schizophrenia led to a vegetative state in patients by their forties, but the use of antipsychotic medications has extended the illness's course. It's important to remember that these symptoms are distortions of normal functions and not a true representation of reality.

    • Schizophrenia: A Developmental Dementia with Disoriented Neurons and Excessive LossSchizophrenia is a complex disorder affecting brain development from birth, causing disoriented neurons, decreased connections, and excessive neuron loss. Characterized as a developmental dementia, it's often undertreated globally.

      Schizophrenia is a complex mental disorder that begins before birth and affects the development and organization of neurons in the brain. This results in disoriented neurons, decreased connections between neurons, and excessive loss of neurons. Individuals with schizophrenia may exhibit catatonic symptoms such as lack of movement, waxy flexibility, and stupor. The discovery of these abnormalities was initially based on post-mortem studies, revealing clumps of neurons in the wrong places and disorganized neurons. Schizophrenia can be characterized as a developmental dementia, with both abnormal neuronal development and excessive loss of connections and neurons occurring throughout childhood and early adolescence. Despite its early onset, schizophrenia is often undertreated in both first and third world countries.

    • Genetics and Environment Factors in SchizophreniaSchizophrenia is a complex condition influenced by genetics and environment. Risk factors include urban environments, birth complications, paternal age, prenatal adversity, stress, infection, malnutrition, family history, and specific gene variations.

      Schizophrenia is a complex illness with both genetic and environmental factors at play. Using the analogy of a computer, if too many wires are clipped, the processing of information becomes disorganized and abnormal. The worldwide risk of schizophrenia is around 1%, but certain factors like urban environments, birth complications, paternal age, prenatal adversity, stress, infection, and malnutrition can increase this risk. Schizophrenia is genetically determined, but environmental factors can trigger the illness in those with a genetic predisposition. The risk of developing schizophrenia increases significantly if a family member has the condition. Having one parent with schizophrenia increases the risk tenfold, and having both parents increases the risk to 40-50%. Identical twins have a 70% risk if one twin has the condition. Marijuana use may promote schizophrenia in a minority of people with a specific gene variation that affects the brain enzyme catechol O methyltransferase. These individuals may experience paranoia and an increased risk of developing a permanent psychotic illness when using marijuana. It's essential to be aware of these risk factors and the role of genetics and environment in the development of schizophrenia.

    • Effects of Marijuana on Adolescents with SchizophreniaMarijuana use during adolescence can worsen symptoms for those with schizophrenia, and those who experience paranoia or hypervigilance should avoid it. Proper medication management and continuous treatment are crucial for mitigating brain loss and preventing relapses.

      The use of marijuana or other cannabinoids during adolescence can have different effects on individuals, and those who experience paranoia or hypervigilance instead of relaxation may want to avoid these substances due to potential risks for those with schizophrenia. Another crucial point is that schizophrenia causes significant brain loss from the second trimester, and the rate of loss accelerates with the onset of psychotic symptoms. Medication adherence can help mitigate this brain loss, and continuous treatment is recommended to prevent relapses and further illness progression. Contrary to some beliefs, long-term antipsychotic use has been shown to be beneficial, as discontinuing medication can lead to relapses and worsening of symptoms. The underlying pathophysiology of schizophrenia suggests that relapses can cause neurotransmitter abnormalities and toxic metabolites, contributing to the loss of neurons and connections between them. Overall, proper medication management and continuous treatment are essential for managing schizophrenia and mitigating its progression.

    • Schizophrenia's Debilitating Impact and Importance of Long-term MedicationSchizophrenia is a severe mental illness with a high suicide rate and potential for brain damage during psychotic episodes. Long-term medication is crucial for managing the illness and preventing relapses, as untreated schizophrenia can lead to a lack of normal, healthy functioning.

      Schizophrenia is a debilitating and potentially lethal mental illness, with a higher suicide rate than major depressive illness. Every psychotic break can result in a loss of brain mass, making it difficult for individuals to return to baseline functioning after each episode. Long-term medication is crucial for managing the illness and preventing relapses, as stopping medication can lead to a high risk of relapse. The vast majority of people with schizophrenia do not regain normal, healthy lives without treatment due to the long-term impact of the illness starting in the womb and not being addressed until adulthood. The studies suggesting that medication-free approaches work for some individuals are often not representative of the entire population with schizophrenia.

    • Preventing Schizophrenia in Children with Family HistoryLow-dose antipsychotics may prevent schizophrenia in kids with family history, reducing risk 5-fold. Predicting risk and long-term treatment is the goal.

      Low-dose antipsychotic medications, such as risperidone and Olanzapine, may have preventive capabilities for schizophrenia in children with a family history of the condition. Studies in Australia have shown a 5-fold decrease in conversion to active illness in those taking these medications. However, since most cases of schizophrenia are sporadic, and we don't have a reliable way to identify those at risk, the long-term goal is to predict who's at risk and prevent the illness through long-term, low-dose antipsychotic treatment. Regarding violence and schizophrenia, people with schizophrenia, particularly those with persecutory or paranoid thoughts, have a greater risk of violent behavior. However, only about 5% of violent crimes are committed by individuals with mental illness. Mass shootings, like those in Aurora, Colorado, and Florida, involve a complex interplay of factors, including mental health issues, but not all shooters are mentally ill. The ability to accurately diagnose and predict mental health issues is crucial for effective prevention and intervention strategies.

    • Mass shooters and mental healthWhile some mass shooters may have mental health issues, not all of them do. Long-term outcomes for schizophrenia improve when long-acting antipsychotics are used earlier and more consistently.

      While some mass shooters may have mental health issues, not all of them do. Those who commit such acts out of political ideologies or a desire for notoriety are not necessarily mentally ill. Regarding schizophrenia, first break psychosis is typically responsive to antipsychotic medication, with a high response rate. However, after five years, the response rate drops significantly. Most psychiatrists start with second-generation antipsychotics, but there's a need to consider long-acting injectable antipsychotics earlier in the illness to prevent relapses and potential brain damage due to non-adherence. In Europe, where long-acting medications are more commonly used, there are better long-term outcomes.

    • Medication Adherence Challenges in SchizophreniaSimplifying medication regimen, educating families, and promoting healthy lifestyle factors can enhance medication adherence and overall well-being for individuals with schizophrenia.

      Medication adherence is a significant challenge in treating schizophrenia, with studies suggesting that around 40% of patients only take 80% of their prescribed antipsychotics. Psychiatrists may underestimate this issue, but it's not uncommon for patients to stop taking their medication and relapse. Simplifying the medication regimen, such as dosing all antipsychotics at bedtime, can increase adherence. Additionally, lifestyle factors like exercise, a healthy diet, and social engagement can improve overall well-being for individuals with schizophrenia. Families of individuals with schizophrenia should educate themselves about the condition to better support their loved ones in managing their medication and maintaining an active, healthy lifestyle.

    • Effective communication and family support for individuals with schizophreniaRecognize schizophrenia as a chronic relapsing brain disease, seek proper treatment, manage family interactions, and maintain a healthy diet to reduce relapses.

      Families play a crucial role in supporting individuals with schizophrenia, and effective communication and understanding between them can lead to better outcomes. Frustration often arises when families struggle to get their loved ones the necessary help within the current medical care system. High expressed emotion, particularly negative or critical comments, can destabilize individuals with schizophrenia and potentially lead to relapses. Families can benefit from resources that help them manage interactions with their loved ones and access proper treatment. Anosognosia, or lack of insight into one's own illness, is a common challenge for individuals with schizophrenia, and recognizing the illness as a chronic relapsing brain disease is essential for effective treatment. While more research is needed on optimizing diet for individuals with schizophrenia, a Mediterranean-style or healthy diet is likely beneficial. Overall, family support, proper treatment, and self-recognition are key factors in managing schizophrenia and reducing relapses.

    • Poor dietary habits of individuals with schizophrenia may lead to lower omega-3 fatty acid content in their brainsIndividuals with schizophrenia may not consume enough omega-3s due to poor diets, potentially contributing to brain health issues

      Individuals with schizophrenia often have poor dietary habits, which may contribute to a lower omega-3 fatty acid content in their brains compared to the general population. Omega-3s, found in foods like flaxseed, chia seeds, and salmon, are essential healthy fats that may not be adequately consumed in the diets of people with schizophrenia. While the reason for this lower omega-3 content is not definitively known, it could be due to a lack of access to these nutrient-rich foods or a poor diet overall. This discussion highlights the potential importance of addressing dietary needs in individuals with schizophrenia, and further research may shed light on the role of nutrition in managing this condition. If you have any questions about this topic, feel free to leave them in the show notes, and we may address them in a future episode.

    Recent Episodes from Psychiatry & Psychotherapy Podcast

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    In this episode, we discuss “reflective function,” which is a precursor to the concept of mentalization. Reflective function is best understood not as synonymous with mentalization, but as a scale from -1 to 9, based off certain adult attachment interview questions that measure the person’s ability to describe their own and others’ internal states, motivations, and articulate a nuanced and unique understanding of life from 0 to 12 years old. This scale was developed by attachment researchers at the University of London, including Dr. Howard Steele and Dr. Peter Fonagy.

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    In today’s episode, we talk with Dr. Bruce Perry who co-authored, The Boy Who Was Raised As A Dog, Born For Love: Why Empathy is Essential and Endangered, and What Happened to You? Conversations on Trauma, Resilience, and Healing (2021). We are also joined by Megan White Zappitelli, M.D., a child and adolescent psychiatrist, and Maddison Hussey, M.D., a child and adolescent fellow. 

    Early Psychosis: Detection and Treatment

    Early Psychosis: Detection and Treatment

    In this episode, we are joined by a panel of experts to discuss treatment of psychosis. Experiences of psychosis are common. When these experiences lead to interference in achieving life goals and/or distress, individuals can benefit from seeking evidenced-based care. The earlier individuals experiencing psychosis come to treatment, the better the outcomes. We are all allies in connecting these young people to care and services. Recovery is possible—people living with psychosis experiences can lead full, meaningful, and fulfilling lives. 

    Q&A with Dr. Michael Cummings

    Q&A with Dr. Michael Cummings

    In this episode, we welcome back fan favorite Dr. Michael Cummings and ask questions sent in by listeners. Topics include Schizophrenia, Social Media Trends, and the SSRI controversy. We are thrilled to dedicate an episode that allows individuals to ask pointed questions and glean from Dr. Cummings' expertise. 

    What People Want From Therapy with Linda Michaels

    What People Want From Therapy with Linda Michaels

    Therapies of depth, insight, and relationship have been missing from, if not pushed out of, the public conversation on mental health treatment. After decades of attack from multiple fronts, these therapies are misunderstood, undervalued, and overlooked by the general public. In order to address this challenge and change this trajectory, we must start by listening to the public and understand their needs, values, and preferences about therapy. Dr. Linda Michaels and colleagues conducted an extensive research project, leveraging qualitative and quantitative tools and techniques widely used in the corporate world, focused on “listening” to the public and understanding what people want and need from therapy. 

    Linda Michaels, PsyD, MBA, is a clinical psychologist in private practice in Chicago. She is also chair and co-founder of the Psychotherapy Action Network (PsiAN), a non-profit that advocates for quality therapy. 

    Link to blog here.

    5 Factors and Domains of Psychiatric Care

    5 Factors and Domains of Psychiatric Care

    In this Episode, Dr. David Puder, Dr. Adam Borecky, and Joanie Burns discuss the 5-factor approach to holistic, patient-centered psychiatric care. This approach takes into account that each individual who seeks care is unique in their physiological and psychological make-up and that multiple factors influence both physical and mental health (for better or worse). 

    The 5-factor approach to treatment is based on the importance of sensorium and its pivotal role in regulating thoughts, feelings, and overall mental health. Sensorium is a lens to understand how we focus on various things. Sensorium is total brain function, which fluctuates throughout the day and depends on a number of factors, including sleep, stress levels, and more.

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    In this episode, we are joined by Dr. Anthony W. Bateman and Dr. Peter Fonagy to discuss their expertise on Mentalization. 

    Mentalization refers to the capacity to reflect upon and understand one's own state of mind and the states of mind of others.  This involves recognizing and making sense of one's own and others’ emotions, beliefs, needs and desires.  People use this tool consciously and unconsciously to make sense of others and themselves. Often done automatically, a person may form beliefs about the people they interact with, making assumptions about their mental states. These beliefs tend to have a strong influence on the mental state of the person, whether or not they are correct.

     

    Beginning the Treatment with Jonathan Shedler, PhD

    Beginning the Treatment with Jonathan Shedler, PhD

    Dr. Jonathan Shedler is well known for his work on the efficacy of psychodynamic therapy. He has highlighted the importance of the initial phase of therapy in establishing a foundation for successful treatment. Dr. Shedler strongly believes the consultation phase is crucial to developing a working alliance between client and therapist and building a treatment frame and structure. Without this foundation, there is no mutual understanding about the goal or the purpose of treatment, and psychotherapy should not move forward. Join us in this episode as Dr. Shelder discusses how to create a firm starting foundation in clinical practice.

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    In this week’s episode of the podcast, we will continue our discussion regarding adverse childhood experiences (ACEs) and their influence on the development of future mental health disorders. The greatest predictive factor of the relationship between ACEs and future mental health disorders has to do with the severity, duration, and number of traumatic events. We’ll explore the Childhood Trauma Questionnaire and the data of how ACEs increase the risk of certain personality disorders and psychiatric conditions.

    Link to blog: 

    https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-204-adverse-childhood-experiences-part-2-measurement-impact-on-future-mental-health-dissociation-and-timing-of-trauma

    Related Episodes

    Valproic Acid: History, Mechanism, Treatment in Bipolar, Schizophrenia, Aggression and Side Effects with Dr. Cummings

    Valproic Acid: History, Mechanism, Treatment in Bipolar, Schizophrenia, Aggression and Side Effects with Dr. Cummings

    In this episode, David Puder, M.D. and Michael Cummings, M.D. discuss the history, uses, and side effects of Valproic Acid which is a mood stabilizer for various conditions including: Bipolar Disorder, Schizophrenia, and Borderline Personality Disorder. 

    Link to Blog:

    Catatonia: Diagnosis and Treatment

    Catatonia: Diagnosis and Treatment

    Catatonia is a severe motor syndrome. It is a secondary response to an underlying illness that requires quick diagnosis and treatment. There are many different things that lead to catatonia, so finding out the underlying cause is very important. In this episode, Dr. Cummings and I discuss the history, diagnosis, and treatment of catatonia. 

    Link to resource library.

    Link to Blog.

    Schizophrenia Treatment: Clozapine, LAIs, Technology and Equity with John Kane, MD and Lauren Hanna, MD

    Schizophrenia Treatment: Clozapine, LAIs, Technology and Equity with John Kane, MD and Lauren Hanna, MD

    John M. Kane, MD. is Professor of Psychiatry and Molecular Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

    Dr. Kane earned his medical degree from New York University in New York, New York, and completed his internship and residency in Psychiatry at The Zucker Hillside Hospital. He is a diplomate of the American Board of Psychiatry and Neurology.

    Dr. Kane is the recipient of many awards, including the Lieber Prize, The APA’s Kempf Award and Foundations Prize, the New York State Office of Mental Health Lifetime Achievement Award, and the Dean Award from the American College of Psychiatrists. He has served as President of the American Society of Clinical Psychopharmacology, the Psychiatry Research Society and the Schizophrenia International Research Society.

    Dr. Kane has been the principal investigator on 23 NIH grants focusing on schizophrenia, psychobiology and treatment, recovery, and improving the quality and cost of care. He is the author of over 900 peer-reviewed papers and serves on the editorial boards of numerous journals. 

    Nortriptyline and the Tricyclic Antidepressants with Dr. Cummings

    Nortriptyline and the Tricyclic Antidepressants with Dr. Cummings

    In today’s episode of the podcast, we’ll be doing a deep-dive into nortriptyline, a lesser-talked about medication in psychopharmacology. We’ll cover a little about the history of tricyclic antidepressants (TCAs) as well as the characteristics, side-effects, and indications to consider when prescribing this class of medication.

    Link to Blog.

    Link to Resource Library.